Edible Transgenic Plant Vaccines – An Overview and Update
Klíčová slova:
Transgenic plants, surface antigen, diseases, edible vaccine, plant-derived vaccines, oral immunizationAbstrakt
Plants are used as bioreactors to express antigenic molecules to be administered as vaccines. Edible transgenic plant vaccines (ETPV) are plant materials (recombinant protein subunit vaccines), and the edible plant tissue functions as an oral vaccine. ETPV are mucosal targeted vaccines where stimulation of both systematic and mucosal immune network takes place and these diminish the utilization of conventional animal or bacterial systems. These are prepared by using transgenic plants that express antigen proteins capable of inducing protective immunity against various human and animal diseases to induce specific immune responses. Edible vaccine candidates have been produced in a variety of plant species, including potato, corn, tomato, carrot, lettuce, watermelon, rice, spinach, and much more. A number of clinical trials have produced encouraging results and ETPV offer exciting opportunities for significantly reducing the burden of diseases like hepatitis, cholera and measles, autoimmune disorders like diabetes mellitus-type I, diarrhoea, multiples sclerosis, and rheumatoid arthritis. However, ETPV have a long way to go before they will be ready for large-scale tests in humans and animals for the fight against infectious diseases. Experts are of the opinion that the future of edible vaccines will depend on the production of sufficient quantities, and further, if future clinical trials prove successful, the advantages of edible vaccines would be enormous, especially for developing countries. Furthermore, ETPV may be useful, but the risks to human health and the environment are to be checked.Publikováno
Číslo
Sekce
Licence
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |